(Q50625832)
Statements
1 reference
A phase III trial of intramuscular recombinant interferon beta as treatment for exacerbating-remitting multiple sclerosis: design and conduct of study and baseline characteristics of patients. Multiple Sclerosis Collaborative Research Group (MSCRG). (English)
1 reference
L D Jacobs
1 reference
D L Cookfair
1 reference
R A Rudick
1 reference
R M Herndon
1 reference
J R Richert
1 reference
A M Salazar
1 reference
J S Fischer
1 reference
D E Goodkin
1 reference
C V Granger
1 reference
J H Simon
1 reference
1 June 1995
1 reference
1
1 reference
118-135
1 reference
2
1 reference
Identifiers
1 reference